No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Conmed Highlights Growth Strategy at Healthcare Conference
CONMED Corporation to Announce Fourth Quarter 2024 Financial Results on February 5, 2025
BofA Securities Maintains ConMed(CNMD.US) With Hold Rating
The Three-year Underlying Earnings Growth at CONMED (NYSE:CNMD) Is Promising, but the Shareholders Are Still in the Red Over That Time
CONMED Corporation to Present at the J.P. Morgan Healthcare Conference
Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), Conmed (CNMD) and Veeva Systems (VEEV)